218 related articles for article (PubMed ID: 23896123)
1. Enhancement of protective immune response to recombinant Toxoplasma gondii ROP18 antigen by ginsenoside Re.
Qu D; Han J; Du A
Exp Parasitol; 2013 Oct; 135(2):234-9. PubMed ID: 23896123
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
[TBL] [Abstract][Full Text] [Related]
3. Ginseng Stem-and-Leaf Saponin (GSLS)-Enhanced Protective Immune Responses Induced by Toxoplasma gondii Heat Shocked Protein 70 (HSP70) Against Toxoplasmosis in Mice.
Zhuo X; Sun H; Wang S; Guo X; Ding H; Yang Y; Shan Y; Du A
J Parasitol; 2017 Feb; 103(1):111-117. PubMed ID: 27828760
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.
Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ
Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the protective efficacy of a ROP18 vaccine against chronic toxoplasmosis by nasal route.
Rashid I; Moiré N; Héraut B; Dimier-Poisson I; Mévélec MN
Med Microbiol Immunol; 2017 Feb; 206(1):53-62. PubMed ID: 27757545
[TBL] [Abstract][Full Text] [Related]
9. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18.
Yuan ZG; Zhang XX; Lin RQ; Petersen E; He S; Yu M; He XH; Zhou DH; He Y; Li HX; Liao M; Zhu XQ
Vaccine; 2011 Sep; 29(38):6614-9. PubMed ID: 21762755
[TBL] [Abstract][Full Text] [Related]
10. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
11. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunisation of the recombinant Toxoplasma gondii receptor for activated C kinase 1 partly protects mice against T. gondii infection.
Wang HL; Pang M; Yin LT; Zhang JH; Meng XL; Yu BF; Guo R; Bai JZ; Zheng GP; Yin GR
Acta Trop; 2014 Sep; 137():58-66. PubMed ID: 24813415
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: protective immunity against experimental toxoplasmosis induced by a DNA vaccine encoding the perforin-like protein 1.
Yan HK; Yuan ZG; Petersen E; Zhang XX; Zhou DH; Liu Q; He Y; Lin RQ; Xu MJ; Chen XL; Zhong XL; Zhu XQ
Exp Parasitol; 2011 May; 128(1):38-43. PubMed ID: 21310148
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II.
Tan F; Hu X; Luo FJ; Pan CW; Chen XG
Vaccine; 2011 Mar; 29(15):2742-8. PubMed ID: 21315696
[TBL] [Abstract][Full Text] [Related]
15. Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection.
Sánchez VR; Pitkowski MN; Fernández Cuppari AV; Rodríguez FM; Fenoy IM; Frank FM; Goldman A; Corral RS; Martin V
Exp Parasitol; 2011 Aug; 128(4):448-53. PubMed ID: 21554876
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes.
Wang T; Yin H; Li Y; Zhao L; Sun X; Cong H
Parasite; 2017; 24():12. PubMed ID: 28367800
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
[TBL] [Abstract][Full Text] [Related]
18. Immuno-efficacy of DNA vaccines encoding PLP1 and ROP18 against experimental Toxoplasma gondii infection in mice.
Chen Y; Yu M; Hemandez JA; Li J; Yuan ZG; Yan H
Exp Parasitol; 2018 May; 188():73-78. PubMed ID: 29626423
[TBL] [Abstract][Full Text] [Related]
19. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
Cui X; Lei T; Yang D; Hao P; Li B; Liu Q
Vaccine; 2012 Mar; 30(13):2282-7. PubMed ID: 22310204
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
